BioPen uses 3D bioprinting technology to enable surgeons draw viable human stem cells in order to reconstruct bones of damaged joints. The product is still at the R&D stage and is still being actively tested and improved.
The initial study was conducted with rats, but it was confirmed that the researchers seek to extend the new findings to human. The biodegradable chip was expected to help doctors monitor their patients better while reducing risks of removal re-operation, such as infections.
Doctors and health professionals from both sides of the Pacific on Thursday said they worry that a major regional trade pact could result in higher medical costs and urged a full assessment of the pact's impact on healthcare.